| Financial Year |
March 31 2023 |
| Monetary Funds |
1,110,758,600.71 |
| Held-for-trading Financial Assets |
314,128,581.46 |
| Notes Receivable |
273,944,841.71 |
| Accounts Receivable |
3,785,813,095.53 |
| Advances to Suppliers |
69,645,402.92 |
| Other Receivables |
106,108,841.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
400,000.00 |
| Inventories |
1,314,544,496.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,268,591.72 |
| Total Current Assets |
7,254,140,761.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
401,193,484.06 |
| Investment Properties |
-- |
| Fixed Assetes |
1,161,124,025.87 |
| Under-construction Projects |
106,342,319.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
481,167,871.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
89,061,803.75 |
| Deferred Income Tax Assets |
153,238,015.58 |
| Other Non-Current Assets |
34,126,531.96 |
| Sub-Total of Non-Current Assets |
2,615,940,534.34 |
| Total Assets |
9,870,081,296.16 |
| Short-Term Loans |
361,115,820.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
742,923,578.33 |
| Accounts Payable |
2,348,536,448.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
291,740,532.47 |
| Taxes Payable |
85,002,336.73 |
| Interest Payable |
-- |
| Dividend Payable |
21,280,000.00 |
| Other payables |
75,104,218.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,177,938.78 |
| Other Current Liabilities |
251,472,650.52 |
| Sub-Total of Current Liabilities |
4,362,425,066.27 |
| Long-term Loans |
298,118,757.28 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,185,031.61 |
| Deferred Income Tax Liabilities |
47,142,366.79 |
| Other Non-Current Liabilities |
12,693,389.96 |
| Sub-Total of Non-Current Liabilities |
549,885,125.00 |
| Total Liabilities |
4,912,310,191.27 |
| Paid-In Capital(Or Share Stock) |
321,540,000.00 |
| Capital Surplus |
1,184,869,908.45 |
| Surplus Reserve |
160,770,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,083,922,826.72 |
| Minority Stockholder's Interest |
203,576,432.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,754,194,672.45 |
| Owner's Equity（Stockholder's Equity） |
4,957,771,104.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,870,081,296.16 |
